Lung Cancer
A Phase 1/2 Clinical Trial of Quaratusugene Ozeplasmid and Atezolizumab Maintenance Therapy in Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ONC-005)
- Details
ClinicalTrials.gov ID:
NCT05703971
Diagnosis Type:
NA
USOR Number:
- Address
,
P: